Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant anti-CD4 antibodies for human therapy

Recombinant anti-CD4 antibodies for human therapy

US Patent 6136310 · Granted Oct 24, 2000

Estimated economic value: $203,936,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Drug conjugates of cMET monoclonal binding agents, and uses thereof2024
CMET monoclonal binding agents, drug conjugates thereof and uses thereof2022
Syndecan-1 (CD138) binding agents and uses thereof2022
Antibody-fynomer conjugates2019
Modified binding molecules comprising connecting peptides2013
Expression and use of anti-CD20 Antibodies2010
Expression and use of anti-CD20 Antibodies2010
Expression and use of anti-CD20 Antibodies2010
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2010
Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antib2009
Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-speci2009
Methods of producing 7C10 and 16C10 CD80-specific antibodies2009